Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1995-06-06
1999-01-12
Fitzgerald, David L.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
530351, 930141, 4241921, A61K 3820, C12N 1574
Patent
active
058583475
ABSTRACT:
The present invention relates to fusion molecules composed of human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally joined to a second colony stimulating factor (CSF), cytokine, lymphokine, interleukin or IL-3 variant. These hIL-3 variants contain amino acid substitutions and may also have amino acid deletions at both the N- and C- termini. The invention also relates to pharmaceutical compositions containing the fusion molecules and methods for using them.
REFERENCES:
patent: 4438032 (1984-03-01), Golde et al.
patent: 4810643 (1989-03-01), Souza
patent: 4877729 (1989-10-01), Clark et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 4999291 (1991-03-01), Souza
patent: 5032395 (1991-07-01), Clark et al.
patent: 5073627 (1991-12-01), Curtis et al.
patent: 5108910 (1992-04-01), Curtis et al.
patent: 5218092 (1993-06-01), Sasaki et al.
patent: 5376367 (1994-12-01), Williams
patent: 5516512 (1996-05-01), Dorssers et al.
patent: 5591427 (1997-01-01), Vadas et al.
patent: 5677149 (1997-10-01), Bauer et al.
patent: 5738849 (1998-04-01), Bauer et al.
Dorssers, L.C.J., et al. (1991) J. Biol. Chem. 266: 21310-17.
Olins, P.O., et al. (1995) J. Biol. Chem. 270: 23754-60.
Fojo et al., Biochem. vol. 17--No. 15:3109 (1978).
Park et al., Biotech. vol. 11:Nov. (1993).
Curtis et al, Proc.Natl.Acad.Sci. USA 88:5809 (1991).
Williams et al., Cancer 67:2705-2707 (1991).
Welch et al., Exp. Hem 21:647-655 (1993).
Abrams Mark Allen
Bauer S. Christopher
Braford-Goldberg Sarah Ruth
Caparon Maire Helena
Easton Alan Michael
Bennett Dennis A.
Fitzgerald David L.
G. D. Searle & Co.
LandOfFree
Therapeutic methods using fusion proteins between interleukin-3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic methods using fusion proteins between interleukin-3 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic methods using fusion proteins between interleukin-3 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1511753